Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
26
|
| pubmed:dateCreated |
1979-11-21
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0024-3205
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
25
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2467-73
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:39211-Antipsychotic Agents,
pubmed-meshheading:39211-Blood Proteins,
pubmed-meshheading:39211-Chlorpromazine,
pubmed-meshheading:39211-Female,
pubmed-meshheading:39211-Humans,
pubmed-meshheading:39211-Hydroxylation,
pubmed-meshheading:39211-Male,
pubmed-meshheading:39211-Mesoridazine,
pubmed-meshheading:39211-Protein Binding
|
| pubmed:year |
1979
|
| pubmed:articleTitle |
Antischizophrenic drugs: differential plasma protein binding and therapeutic activity.
|
| pubmed:publicationType |
Journal Article
|